Hesai Group Sponsored ADR (HSAI) stock: key figures, P/E, revenue and dividend
Consumer Discretionary · United States · ISIN US4280501085
Hesai Group Sponsored ADR financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 3.03 bn CNY |
| Gross profit | 1.27 bn CNY |
| Operating income | 168.75 m CNY |
| EBIT | 123.00 m CNY |
| Net income | 435.88 m CNY |
| Diluted EPS – continuing operations | 2.68 CNY |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hesai Group Sponsored ADR
Hesai Group, through with its subsidiaries, engages in the development, manufacturing, and sale of three-dimensional light detection and ranging solutions (LiDAR) in Mainland China, Europe, North America, and internationally. The company provides gas sensor products, validation services, solution service, and other services, as well as designs and develops engineering products. Its LiDAR products are used in passenger and commercial vehicles with advanced driver assistance systems; autonomous vehicle fleets providing passenger and freight mobility services; and other applications, such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas. Hesai Group was founded in 2014 and is headquartered in Shanghai, China.
More stocks
- C Sun Manufacturing Ltd (2467.TW)
- Artisan Partners Asset Management Inc. (APAM)
- Ternium Argentina SA (TXAR.BA)
- Kojamo Oyj (KOJAMO.HE)
- Currys PLC (CURY.L)
- Xinyi Solar Holdings Ltd (968.HK)
- WAFD INC (WAFD)
- Cosmax Inc (192820.KS)
- Worthington Steel, Inc. (WS)
- Guangzhou Kingmed Diagnostics Group Co Ltd (603882.SS)
- Cadeler A/S (CADLR.OL)
- RECURSION PHARMACEUTICALS, INC. (RXRX)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.